LoginSignup
Medtronic logo

Medtronic

Stock
Stock
ISIN: IE00BTN1Y115
Ticker: MDT
IE00BTN1Y115
MDT

Price

Price

CHART BY

Historical dividends and forecast

All dividend data

Medtronic has so far distributed $2.14 in 2026. The next dividend will be paid on 16.10.2026

$0.971

CHART BY

Frequently asked questions

The market capitalization of Medtronic is $116.11B. Market capitalization is a measure of the total market value of a publicly traded company. It is calculated by multiplying the current stock price by the total number of outstanding shares.
The Price-to-Earnings (P/E) ratio (TTM) for Medtronic is 22.35. This ratio helps investors assess whether a stock is overvalued or undervalued compared to its earnings.
Medtronic's Earnings Per Share (EPS) over the trailing twelve months (TTM) is $4.062. EPS indicates the company's profitability on a per-share basis.
Currently, 29 analysts cover Medtronic's stock, with a consensus target price of $104.00. Analyst ratings provide insights into the stock's expected performance.
Over the trailing twelve months, Medtronic reported a revenue of $37.54B.
Yes, Medtronic is paying dividends. The next payment is scheduled for 16.10.2026, with an expected amount of .
Medtronic's Earnings before interest, taxes, depreciation, and amortization (EBITDA) over the trailing twelve months is $10.42B. EBITDA measures the company's overall financial performance.
Medtronic has a free cash flow of $6.13B. Free cash flow indicates the cash generated after accounting for cash outflows to support operations and capital assets.
Medtronic employs approximately 95,000 people. It operates in the Health Care sector, specifically within the Medical Specialties industry.
The free float of Medtronic is 1.28B. Free float refers to the number of shares available for public trading, excluding restricted shares.

Financials

Market Cap 
$116.11B
EPS (TTM) 
$4.062
Free Float 
1.28B
P/E ratio (TTM) 
22.35
Revenue (TTM) 
$37.54B
EBITDA (TTM) 
$10.42B
Free Cashflow (TTM) 
$6.13B

Pricing

1D span
$88.63$90.26
52W span
$73.31$106.33

Analyst Ratings

The price target is $104.00 and the stock is covered by 29 analysts.

Buy

19

Hold

10

Sell

0

Information

Medtronic Plc is a medical technology company, which engages in the development, manufacture, distribution, and sale of device-based medical therapies and services. It operates through the following segments: Cardiovascular Porrtfolio, Neuroscience Portfolio, Medical Surgical Portfolio, and Diabetes Operating Unit. The Cardiovascular Portfolio segment includes products for the diagnosis, treatment, and management of cardiac rhythm disorders and cardiovascular disease. The Neuroscience Portfolio is made up of cranial and spinal technologies, specialty therapies, and neuromodulation divisions. The Medical Surgical Portfolio is comprised of surgical innovations and respiratory, gastrointestinal, and renal divisions. The Diabetes Group segment offers insulin pumps, continuous glucose monitoring systems, and insulin pump consumables. The company was founded in 1949 and is headquartered in Galway, Ireland.

Employees
95,000
Industries
Medical Specialties
Sector
Health Care

Identifier

ISIN
IE00BTN1Y115
Primary Ticker
MDT

Knockouts

Real-time data from LSX · Fundamentals & EOD data from FactSet
Join the conversation
Sign upLogin